Literature DB >> 16499934

Altered Bcl-2 and Bax expression is associated with cultured first trimester human cytotrophoblasts apoptosis induced by hypoxia.

Rong Hu1, Shufeng Zhou, Xiaotian Li.   

Abstract

Preeclampsia is associated with placental hypoxia at early gestation. We therefore investigated the effect of hypoxia on the apoptosis of cultured first trimester human cytotrophoblasts and the expression of apoptosis relevant proteins, Bcl-2 and Bax. First trimester human cytotrophoblasts were isolated and cultured under either standard or hypoxic conditions. Cellular apoptosis was monitored by TUNEL and Annexin V binding, and the expression of Bcl-2 and Bax was determined by Western blot analysis. Apoptosis increased significantly in cytotrophoblasts cultured for 24 h under hypoxic conditions in contrast with those cultured under standard conditions, meanwhile expression of Bcl-2 reduced, and that of Bax increased. These changes suggested that hypoxia induced apoptosis in cultured first trimester cytotrophoblasts with altered Bcl-2 and Bax expression. Further study is needed to explore the role of cytotrophoblasts apoptosis in hypoxia-induced maternal and fetal diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16499934     DOI: 10.1016/j.lfs.2006.01.011

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

Review 1.  Mitochondrial Dysfunction in the Pathogenesis of Preeclampsia.

Authors:  Xiang-Qun Hu; Lubo Zhang
Journal:  Curr Hypertens Rep       Date:  2022-03-07       Impact factor: 5.369

2.  Low-dose aspirin inhibits trophoblast cell apoptosis by activating the CREB/Bcl-2 pathway in pre-eclampsia.

Authors:  Kai-Min Guo; Wei Li; Zhao-Hua Wang; Lang-Chi He; Yan Feng; Hui-Shu Liu
Journal:  Cell Cycle       Date:  2022-07-06       Impact factor: 5.173

3.  Protective Effect of Silymarin against Acrolein-Induced Cardiotoxicity in Mice.

Authors:  Elahe Taghiabadi; Mohsen Imenshahidi; Khalil Abnous; Fatemeh Mosafa; Mojtaba Sankian; Bahram Memar; Gholamreza Karimi
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-18       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.